Company Filing History:
Years Active: 2009
Title: Kimm Galbraith: Innovator in Pharmaceutical Chemistry
Introduction
Kimm Galbraith is a notable inventor based in Spring City, MD (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the area of enantiomer conversion processes.
Latest Patents
Kimm Galbraith holds a patent for a conversion process for 2,3-benzodiazepine enantiomers. This patent describes methods for the racemization of an enantiomer of a 2,3-benzodiazepine molecule into the corresponding racemic mixture under either basic or acidic conditions. Furthermore, the invention relates to the conversion of an enantiomer of tofisopam or its metabolites to the corresponding opposite enantiomer.
Career Highlights
Kimm is currently associated with Vela Acquisition Corporation, where he applies his expertise in pharmaceutical innovations. His work has the potential to impact various therapeutic applications, enhancing the efficacy of treatments involving benzodiazepine compounds.
Collaborations
Kimm collaborates with talented individuals in his field, including Yong Victoria Wei and Naidaong Ye. Their combined efforts contribute to advancing research and development in pharmaceutical chemistry.
Conclusion
Kimm Galbraith's innovative work in the conversion of enantiomers showcases his commitment to advancing pharmaceutical science. His contributions are valuable to the industry and highlight the importance of collaboration in research and development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.